126 related articles for article (PubMed ID: 18554334)
1. Apolipoproteins: promising biomarkers for cardiovascular risk prediction.
Romero-Corral A; Somers VK; Lopez-Jimenez F
J Intern Med; 2008 Jul; 264(1):1-3. PubMed ID: 18554334
[No Abstract] [Full Text] [Related]
2. Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin.
May A; Wang TJ
Expert Rev Mol Diagn; 2007 Nov; 7(6):793-804. PubMed ID: 18020909
[TBL] [Abstract][Full Text] [Related]
3. [Determination of apolipoproteins: An important tool for prevention and treatment of cardiovascular diseases].
Wiklund O
Lakartidningen; 2007 May 14-29; 104(20-21):1623-4. PubMed ID: 17564272
[No Abstract] [Full Text] [Related]
4. [Apolipoprotein A-I, A-II, A-IV].
Kazumi T; Yoshino G
Nihon Rinsho; 2004 Dec; 62 Suppl 12():98-100. PubMed ID: 15658273
[No Abstract] [Full Text] [Related]
5. Multiple biomarkers for the prediction of first major cardiovascular events and death: considerable costs and limited benefits.
Lippi G; Salvagno GL; Targher G; Guidi GC
MedGenMed; 2007 Feb; 9(1):34. PubMed ID: 17435640
[No Abstract] [Full Text] [Related]
6. Biomarkers for cardiovascular disease: challenges and future directions.
May A; Wang TJ
Trends Mol Med; 2008 Jun; 14(6):261-7. PubMed ID: 18487087
[TBL] [Abstract][Full Text] [Related]
7. [Laboratory assessment of HDL heterogeneity and function].
Movva R; Rader DJ
Ann Biol Clin (Paris); 2009; 67(1):7-21. PubMed ID: 19189882
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of high risk of heart disease among asymptomatic persons].
Holme I; Hjermann I
Tidsskr Nor Laegeforen; 2002 Sep; 122(21):2132-3. PubMed ID: 12555653
[No Abstract] [Full Text] [Related]
9. Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease.
Ioannidis JP; Tzoulaki I
Circ Res; 2012 Mar; 110(5):658-62. PubMed ID: 22383708
[No Abstract] [Full Text] [Related]
10. Identification of biomarkers for risk stratification of cardiovascular events using genetic algorithm with recursive local floating search.
Zhou X; Wang H; Wang J; Wang Y; Hoehn G; Azok J; Brennan ML; Hazen SL; Li K; Chang SF; Wong ST
Proteomics; 2009 Apr; 9(8):2286-94. PubMed ID: 19337989
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers for cardiovascular disease: cardiovascular biomarkers to proteomic discovery.
Suzuki T; Nagai R
Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):295. PubMed ID: 18506210
[No Abstract] [Full Text] [Related]
12. Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar.
Welsh P; Packard CJ; Sattar N
Curr Opin Lipidol; 2008 Dec; 19(6):563-71. PubMed ID: 18957878
[TBL] [Abstract][Full Text] [Related]
13. [Should apolipoproteins be the first choice in routine health care?].
Järhult B; Lindström K
Lakartidningen; 2007 Oct 17-23; 104(42):3124. PubMed ID: 17985715
[No Abstract] [Full Text] [Related]
14. Role of biomarkers in predicting CVD risk in the setting of HIV infection?
Worm SW; Hsue P
Curr Opin HIV AIDS; 2010 Nov; 5(6):467-72. PubMed ID: 20978389
[TBL] [Abstract][Full Text] [Related]
15. [Apolipoproteins are better risk markers than conventional lipids].
Walldius G; Holme I; Jungner I
Lakartidningen; 2007 Sep 12-18; 104(37):2612-3. PubMed ID: 17970399
[No Abstract] [Full Text] [Related]
16. Biomarkers of cardiovascular disease: molecular basis and practical considerations.
Vasan RS
Circulation; 2006 May; 113(19):2335-62. PubMed ID: 16702488
[No Abstract] [Full Text] [Related]
17. [Final reply on the introduction of apolipoprotein determination in Jonkoping: need of ethical platform in the county council].
Järhult B; Lindahl SO; Lindström K
Lakartidningen; 2007 Mar 28-Apr 3; 104(13):1065. PubMed ID: 17476915
[No Abstract] [Full Text] [Related]
18. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.
Koenig W
Ann Med; 2009; 41(5):332-43. PubMed ID: 19291518
[TBL] [Abstract][Full Text] [Related]
19. Apolipoproteins: emerging biomarkers for CAD.
Goswami B
Singapore Med J; 2010 Feb; 51(2):179. PubMed ID: 20358162
[No Abstract] [Full Text] [Related]
20. Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease.
Hurks R; Peeters W; Derksen WJ; Hellings WE; Hoefer IE; Moll FL; de Kleijn DP; Pasterkamp G
Thromb Haemost; 2009 Jan; 101(1):48-54. PubMed ID: 19132188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
